AnalystsLee HambrightLee Hambright's Stock Forecasts
AnalystsLee Hambright
Analyst Ranking
Top 30%
#1520 out of 5177 analysts
Average Return
+5.92%
Win Rate
60%15 out of 25
Risk vs Reward
Poor
Good
Lee Hambright's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Dexcom IncDXCM | +73.52% | $79.14 | $137.32 | 2022-07-14 - 2023-07-14 | Buy |
Insulet CorpPODD | +31.40% | $239.30 | $314.44 | 2024-11-05 - 2025-11-05 | Buy |
Intuitive Surgical IncISRG | +31.04% | $307.84 | $403.39 | 2023-05-30 - 2024-05-30 | Buy |
Edwards Lifesciences CorpEW | +24.63% | $21.67 | $27.00 | 2014-12-03 - 2015-12-04 | Buy |
Intuitive Surgical IncISRG | +23.18% | $297.41 | $366.34 | 2023-04-19 - 2024-04-19 | Buy |
Lee Hambright Analyst Color
Get additional color on Lee Hambright's coverage of popular stocks
Lee Hambright's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Medline IncMDLN | 1 | Buy | $49.00 | +11.06% | Initiates Coverage On | 5 days ago |
Zimmer Biomet Holdings IncZBH | 2 | Hold | $99.00 | +13.39% | Maintains | 8 days ago |
Tandem Diabetes Care IncTNDM | 2 | Hold | $25.00 | +24.01% | Maintains | 8 days ago |
Stryker CorpSYK | 2 | Buy | $465.00 | +27.82% | Maintains | 8 days ago |
Insulet CorpPODD | 2 | Buy | $380.00 | +32.08% | Maintains | 8 days ago |
Medtronic PLCMDT | 4 | Buy | $112.00 | +15.75% | Maintains | 8 days ago |
Johnson & JohnsonJNJ | 3 | Hold | $208.00 | -4.88% | Maintains | 8 days ago |
Intuitive Surgical IncISRG | 3 | Buy | $740.00 | +38.32% | Maintains | 8 days ago |
Dexcom IncDXCM | 3 | Buy | $86.00 | +23.67% | Maintains | 8 days ago |
Abbott LaboratoriesABT | 6 | Buy | $154.00 | +26.48% | Maintains | 8 days ago |
Boston Scientific CorpBSX | 1 | Buy | $100.00 | N/A | Maintains | a year ago |
Edwards Lifesciences CorpEW | 3 | Buy | $135.00 | N/A | Upgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.